Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
Feb 23, 2024, 18:03 |
Blog
Vivek Subbiah: The development of armored CAR T-cells may enable CAR T to be efficacious against a broader range of malignancies
Vivek Subbiah recently shared on LinkedIn: "'CARs are sharpening their weapons'. The development of armored…
Feb 23, 2024, 17:40 |
Drugs
Nicole Verdun: We granted accelerated approval for Amtagvi (lifileucel), manufactured by Iovance Biotherapeutics
Nicole Verdun, Super Office Director at FDA, recently posted on LinkedIn: "I am pleased to…
Feb 23, 2024, 17:26 |
Blog
Elad Sharon: Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in sarcoma!
Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, made the following post on X: "Honored…
Feb 23, 2024, 11:08 |
Insight
Provides an overview of oncology drugs approved the previous year - Nature Reviews Clinical Oncology
Nature Reviews Clinical Oncology shared a post on X: "One more year FDA Oncology provides an…
Feb 22, 2024, 23:27 |
Blog
Amalya Sargsyan: First approved T cell therapy for solid tumors
Amalya Sargsyan, Medical Oncologist at Yeolyan Hematology and Oncology Center, shared a post by Nicholas Restifo,…
Feb 22, 2024, 23:12 |
Blog
Vivek Subbiah: A look at breakthrough treatment for sickle cell anemia
Vivek Subbiah shared on X: “Jimi and Victoria met in person for the first time…
Feb 20, 2024, 18:51 |
Blog
Vivek Subbiah: Our editorial comments on the ASCO TAPUR study spearheaded by the amazing Richard Schilsky
Vivek Subbiah recently shared on X/Twitter: "Hot off the press Pleased to share our editorial…
Feb 18, 2024, 14:31 |
Blog
Vivek Subbiah: Is this the future?
Vivek Subbiah shared a post on LinkedIn: “The future of precision cancer therapy might be…
Feb 17, 2024, 17:47 |
Insight
Vivek Subbiah: Delighted to share Modernize Precision Oncology With Decentralized Trial Tools
Vivek Subbiah shared a post on X: "Hot off the press JAMA Oncology: Delighted to…
Feb 14, 2024, 19:39 |
Drugs
Bishal Gyawali: A pseudo-innovation for which you get to pay more without any added benefits
Bishal Gyawali, Associate Professor and Medical Oncologist at Queen’s University, shared a post on X/Twitter: "Read…
78
79
80
81
82
All:
951
Posts:
791 - 800
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube